The Thoroughbred Owners and Breeders Association has delayed implementation of its drug-testing protocol for graded stakes in the United States because not all jurisdictions were prepared to implement it, the American Graded Stakes Committee sai

Three months after national regulators’ associations approved model rules for a proposed national medication policy, the task of lobbying jurisdictions to adopt them continues.

The Association of Racing Commissioners International and th

The FDA recently approved a new non-steroidal anti-inflammatory drug (NSAID) that can be applied to the skin over a horse’s joint to relieve pain of osteoarthritis. The approval represents the first topical equine pharmaceutical formulation

Schering-Plough Animal Health has announced that Banamine Injectable Solution, a non-steroidal anti-inflammatory (NSAID) drug for horses, is available again to treat inflammation and pain associated with musculoskeletal disorders and colic.

Spectators at the Rolex Kentucky Three-Day Event in Lexington and area horse owners will have the opportunity to hear about some of the latest veterinary technologies for the sport horse from top veterinarians on April 22 after the first day of

(Updated Story) A jury awarded $1,007,500 to plaintiffs who alleged in a lawsuit that Farnam’s Equitrol, a feed-through fly control product, was defectively designed and caused harm to their Thoroughbred and Warmblood sport horses.

The University of Kentucky’s (UK) equine drug research program, funded by pari-mutuel handle under the auspices of the Kentucky Horse Racing Authority, has been suspended indefinitely.

A memorandum obtained by The